Covid-19 Research

Research Article

Challenges and Opportunities to Develop Diagnostics and Therapeutic Interventions for Severe Acute Respiratory Syndrome- Corona Virus 2 (SARS-COV-2)

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Research Article
Subject Biology Group
OCLC 8686848985
Jaison Jeevanandam, Subhamoy Banerjee and Rajkumar Paul*
Issue: Volume1-Issue6
Pages: 219-232
Received: 2020-09-21
Accepted: 2020-10-12
Published: 2020-10-19

Abstract

Severe Acute Respiratory Syndrome-Corona Virus 2 (SARS-CoV-2) or Corona Virus Disease 19 (COVID-19) is playing havoc all over the world since December 2019. Despite being a family member of coronaviridae, which has previously affected mankind twice in last one decade, the novel corona virus, as it is named left medical practitioners and scientists defenseless. The major challenge is twofold identification and therapeutic intervention. Several approaches, including real-time PCR have already been taken for quick identification of Covid19. Due to very fast evolving rate, accurate identification is still a challenge for most of the detection methods developed in last three months. Several proposals for therapeutic intervention have also put forth by scientists, ranging from vaccine to RNA therapy. In this article, a comprehensive review is made from the scattered scientific literatures and is fine-tuned further with possible diagnostic and therapeutic interventions.

FullText HTML FullText PDF DOI: 10.37871/jbres1147 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2020 Paul R, et al. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Jeevanandam J, Banerjee S, Paul R. Challenges and Opportunities to Develop Diagnostics and Therapeutic Interventions for Severe Acute Respiratory Syndrome- Corona Virus 2 (SARS-COV-2). J Biomed Res Environ Sci. 2020 Oct 19; 1(6): 219-232. doi: 10.37871/jbres1147, Article ID: jbres1147

Subject area(s)

AntiretrovirologyAntivirologyBiologyInfectious Diseases

University/Institute

Universidade da Madeira

References

  1. Kim JM, Chung YS, Jo HJ, Lee NJ, Kim MS, Woo SH, Park S, Kim JW, Kim HM, Han MG. Identification of Coronavirus Isolated from a Patient in Korea with COVID-19. Osong Public Health Res Perspect. 2020 Feb;11(1):3-7. doi: 10.24171/j.phrp.2020.11.1.02. PMID: 32149036; PMCID: PMC7045880.
  2. Poutanen SM. Human Coronaviruses. Principles and Practice of Pediatric Infectious Diseases. 2012:1117-1120.e4. doi: 10.1016/B978-1-4377-2702-9.00224-5. Epub 2013 Feb 10. PMCID: PMC7152163.
  3. Daga MK, Kumar N, Aarthi J, Govind Mawari. From SARS-CoV to Coronavirus Disease 2019 (COVID-19)-A Brief Review. Journal of Advanced Research in Medicine. 2019;(4):1-9. doi: 10.24321/2349.7181.201917
  4. Amanat F, Krammer F. SARS-CoV-2 Vaccines: Status Report. Immunity. 2020 Apr 14;52(4):583-589. doi: 10.1016/j.immuni.2020.03.007. Epub 2020 Apr 6. PMID: 32259480; PMCID: PMC7136867.
  5. Gorbalenya AE, Baker SC, Baric RS. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536-544. doi: 10.1038/s41564-020-0695-z.
  6. Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, Guo GY, Du J, Zheng CL, Zhu Q, Hu M, Li XY, Peng P, Shi HZ. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: A prospective cohort study. Eur Respir J. 2020 May 7;55(5):2000524. doi: 10.1183/13993003.00524-2020. Erratum in: Eur Respir J. 2020 Sep 24;56(3): PMID: 32269088; PMCID: PMC7144257.
  7. Roussel Y, Giraud-Gatineau A, Jimeno MT, Rolain JM, Zandotti C, Colson P, Raoult D. SARS-CoV-2: Fear versus data. Int J Antimicrob Agents. 2020 May;55(5):105947. doi: 10.1016/j.ijantimicag.2020.105947. Epub 2020 Mar 19. PMID: 32201354; PMCID: PMC7102597.
  8. Jiang X, Rayner S, Luo MH. Does SARS-CoV-2 has a longer incubation period than SARS and MERS? J Med Virol. 2020 May;92(5):476-478. doi: 10.1002/jmv.25708. Epub 2020 Feb 24. PMID: 32056235; PMCID: PMC7166592.
  9. Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, Mayhew S. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020 May;19(5):305-306. doi: 10.1038/d41573-020-00073-5. PMID: 32273591.
  10. Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J, Sheng J, Quan L, Xia Z, Tan W, Cheng G, Jiang T. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell Host Microbe. 2020 Mar 11;27(3):325-328. doi: 10.1016/j.chom.2020.02.001. Epub 2020 Feb 7. PMID: 32035028; PMCID: PMC7154514.
  11. Williamson BN, Feldmann F, Schwarz B, Meade-White K, Porter DP, Schulz J, van Doremalen N, Leighton I, Kwe Yinda C, Pérez-Pérez L, Okumura A, Lovaglio J, Hanley PW, Saturday G, Bosio CM, Anzick S, Barbian K, Cihlar T, Martens C, Scott DP, Munster VJ, de Wit E. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. bioRxiv [Preprint]. 2020 Apr 22:2020.04.15.043166. doi: 10.1101/2020.04.15.043166. Update in: Nature. 2020 Jun 9. PMID: 32511319; PMCID: PMC7239049.
  12. Walls AC, Park YJ, Tortorici MA, Abigail Wall, Andrew TM Guire, David Veesler. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181(2):281-292e6.
  13. https://tinyurl.com/rca7ukk
  14. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020 Apr;92(4):418-423. doi: 10.1002/jmv.25681. Epub 2020 Feb 7. Erratum in: J Med Virol. 2020 Aug 2. PMID: 31967327; PMCID: PMC7167049.
  15. Pervushin K, Tan E, Parthasarathy K, Lin X, Jiang FL, Yu D, Vararattanavech A, Soong TW, Liu DX, Torres J. Structure and inhibition of the SARS coronavirus envelope protein ion channel. PLoS Pathog. 2009 Jul;5(7):e1000511. doi: 10.1371/journal.ppat.1000511. Epub 2009 Jul 10. PMID: 19593379; PMCID: PMC2702000.
  16. Fehr AR, Perlman S. Coronaviruses: An overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1-23. doi: 10.1007/978-1-4939-2438-7_1. PMID: 25720466; PMCID: PMC4369385.
  17. Kang S, Yang M, Hong Z, Zhang L, Huang Z, Chen X, He S, Zhou Z, Zhou Z, Chen Q, Yan Y, Zhang C, Shan H, Chen S. Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. Acta Pharm Sin B. 2020 Jul;10(7):1228-1238. doi: 10.1016/j.apsb.2020.04.009. Epub 2020 Apr 20. PMID: 32363136; PMCID: PMC7194921.
  18. McBride R, van Zyl M, Fielding BC. The coronavirus nucleocapsid is a multifunctional protein. Viruses. 2014 Aug 7;6(8):2991-3018. doi: 10.3390/v6082991. PMID: 25105276; PMCID: PMC4147684.
  19. Tanaka T, Kamitani W, DeDiego ML, Enjuanes L, Matsuura Y. Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA. J Virol. 2012 Oct;86(20):11128-37. doi: 10.1128/JVI.01700-12. Epub 2012 Aug 1. PMID: 22855488; PMCID: PMC3457165.
  20. Lei J, Kusov Y, Hilgenfeld R. Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein. Antiviral Res. 2018 Jan;149:58-74. doi: 10.1016/j.antiviral.2017.11.001. Epub 2017 Nov 8. PMID: 29128390; PMCID: PMC7113668.
  21. Stobart CC, Sexton NR, Munjal H, Lu X, Molland KL, Tomar S, Mesecar AD, Denison MR. Chimeric exchange of coronavirus nsp5 proteases (3CLpro) identifies common and divergent regulatory determinants of protease activity. J Virol. 2013 Dec;87(23):12611-8. doi: 10.1128/JVI.02050-13. Epub 2013 Sep 11. PMID: 24027335; PMCID: PMC3838113.
  22. Zhu X, Fang L, Wang D, Dang Wang, Yuting Yang, Jiyao Chen, Xu Ye, Mohamed Frahat Foda, Shaobo Xiao. Porcine deltacoronavirus nsp5 inhibits interferon-beta production through the cleavage of NEMO. Virology. 2017;502: 33-38.
  23. https://tinyurl.com/yyrs7wct
  24. Cottam EM, Whelband MC, Wileman T. Coronavirus NSP6 restricts autophagosome expansion. Autophagy. 2014 Aug;10(8):1426-41. doi: 10.4161/auto.29309. Epub 2014 Jun 11. PMID: 24991833; PMCID: PMC4203519.
  25. te Velthuis AJ, Arnold JJ, Cameron CE, van den Worm SH, Snijder EJ. The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent. Nucleic Acids Res. 2010 Jan;38(1):203-14. doi: 10.1093/nar/gkp904. Epub 2009 Oct 29. Erratum in: Nucleic Acids Res. 2011 Nov;39(21):9458. PMID: 19875418; PMCID: PMC2800238.
  26. Minskaia E, Hertzig T, Gorbalenya AE, Campanacci V, Cambillau C, Canard B, Ziebuhr J. Discovery of an RNA virus 3’->5’ exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5108-13. doi: 10.1073/pnas.0508200103. Epub 2006 Mar 20. PMID: 16549795; PMCID: PMC1458802.
  27. Deng X, Hackbart M, Mettelman RC, O’Brien A, Mielech AM, Yi G, Kao CC, Baker SC. Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages. Proc Natl Acad Sci U S A. 2017 May 23;114(21):E4251-E4260. doi: 10.1073/pnas.1618310114. Epub 2017 May 8. PMID: 28484023; PMCID: PMC5448190.
  28. Chen Y, Su C, Ke M, Jin X, Xu L, Zhang Z, Wu A, Sun Y, Yang Z, Tien P, Ahola T, Liang Y, Liu X, Guo D. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2’-O-methylation by nsp16/nsp10 protein complex. PLoS Pathog. 2011 Oct;7(10):e1002294. doi: 10.1371/journal.ppat.1002294. Epub 2011 Oct 13. PMID: 22022266; PMCID: PMC3192843.
  29. Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, Li F. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734. doi: 10.1073/pnas.2003138117. Epub 2020 May 6. PMID: 32376634; PMCID: PMC7260975.
  30. Pirofski LA, Casadevall A. The Damage-Response Framework as a Tool for the Physician-Scientist to Understand the Pathogenesis of Infectious Diseases. J Infect Dis. 2018 Aug 14;218(suppl_1):S7-S11. doi: 10.1093/infdis/jiy083. PMID: 30124977; PMCID: PMC6093430.
  31. Marco Cascella, Michael Rajnik, Arturo Cuomo, Scott CD, Raffaela DN. Features, evaluation and treatment coronavirus (COVID-19), in Statpearls. 2020; StatPearls Publishing.
  32. Gengler I, Wang JC, Speth MM, Sedaghat AR. Sinonasal pathophysiology of SARS-CoV-2 and COVID-19: A systematic review of the current evidence. Laryngoscope Investig Otolaryngol. 2020 Apr 16;5(3):354-359. doi: 10.1002/lio2.384. PMID: 32587887; PMCID: PMC7262250.
  33. Barnett ML, Mehrotra A, Landon BE. Covid-19 and the Upcoming Financial Crisis in Health Care. NEJM Catalyst Innovations in Care Delivery. 2020;1(2). doi: 10.1056/CAT.20.0153
  34. Ripoll S, Gercama I, Jones T. Social Science in Epidemics: Ebola Virus Disease Lessons Learned. 2018.
  35. https://tinyurl.com/y6fo3kx4
  36. Yang X, Yu Y, Xu J, Huaqing Shu, Jia’an Xia, Hong Liu, Yongran Wu, Lu Zhang, Zhui Yu, Minghao Fang, Ting Yu, Yaxin Wang, Shangwen Pan, Xiaojing Zou, Shiying Yuan, You Shang. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020 May;8(5): 475-481. doi: 10.1016/S2213-2600(20)30079-5
  37. Xu J, Zhao S, Teng T, Abdalla AE, Zhu W, Xie L, Wang Y, Guo X. Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses. 2020 Feb 22;12(2):244. doi: 10.3390/v12020244. PMID: 32098422; PMCID: PMC7077191.
  38. Wang M, Li M, Ren R, Li L, Chen EQ, Li W, Ying B. International Expansion of a Novel SARS-CoV-2 Mutant. J Virol. 2020 Jun 1;94(12):e00567-20. doi: 10.1128/JVI.00567-20. PMID: 32269121; PMCID: PMC7307084.
  39. Khedkar PH, Patzak A. SARS-CoV-2: What do we know so far? Acta Physiol (Oxf). 2020 Jun;229(2):e13470. doi: 10.1111/apha.13470. Epub 2020 Apr 11. PMID: 32220035; PMCID: PMC7228362.
  40. Hoffmann M, Kleine-Weber H, Pöhlmann S. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. Mol Cell. 2020 May 21;78(4):779-784.e5. doi: 10.1016/j.molcel.2020.04.022. Epub 2020 May 1. PMID: 32362314; PMCID: PMC7194065.
  41. Chatterjee S. Understanding the Nature of Variations in Structural Sequences coding for Coronavirus Spike, Envelope, Membrane and Nucleocapsid Proteins of SARS-CoV-2. Envelope, Membrane and Nucleocapsid Proteins of SARS-CoV-2. 2020 March; 1-18.
  42. https://tinyurl.com/yxe2fqgv
  43. Luan J, Lu Y, Jin X, Zhang L. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection. Biochem Biophys Res Commun. 2020 May 21;526(1):165-169. doi: 10.1016/j.bbrc.2020.03.047. Epub 2020 Mar 19. PMID: 32201080; PMCID: PMC7102515.
  44. Wilson NM, Norton A, Young FP, Collins DW. Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review. Anaesthesia. 2020 Aug;75(8):1086-1095. doi: 10.1111/anae.15093. Epub 2020 May 8. PMID: 32311771; PMCID: PMC7264768.
  45. Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D, Sampaziotis F, Worlock KB, Yoshida M, Barnes JL; HCA Lung Biological Network. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020 May;26(5):681-687. doi: 10.1038/s41591-020-0868-6. Epub 2020 Apr 23. PMID: 32327758.
  46. Kowalik MM, Trzonkowski P, Łasińska-Kowara M, Mital A, Smiatacz T, Jaguszewski M. COVID-19 - Toward a comprehensive understanding of the disease. Cardiol J. 2020;27(2):99-114. doi: 10.5603/CJ.a2020.0065. Epub 2020 May 7. PMID: 32378729.
  47. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17. PMID: 32182409; PMCID: PMC7121658.
  48. Meselson M. Droplets and Aerosols in the Transmission of SARS-CoV-2. N Engl J Med. 2020 May 21;382(21):2063. doi: 10.1056/NEJMc2009324. Epub 2020 Apr 15. PMID: 32294374; PMCID: PMC7179963.
  49. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020 Mar 17;94(7):e00127-20. doi: 10.1128/JVI.00127-20. PMID: 31996437; PMCID: PMC7081895.
  50. Ruggiero E, Richter SN. G-quadruplexes and G-quadruplex ligands: targets and tools in antiviral therapy. Nucleic Acids Res. 2018 Apr 20;46(7):3270-3283. doi: 10.1093/nar/gky187. PMID: 29554280; PMCID: PMC5909458.
  51. Sims AC, Baric RS, Yount B, Burkett SE, Collins PL, Pickles RJ. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol. 2005 Dec;79(24):15511-24. doi: 10.1128/JVI.79.24.15511-15524.2005. PMID: 16306622; PMCID: PMC1316022.
  52. Wickramaratchi MM, Pieris A, Fernando AJS. Review on Identification of Major Infectious Site and Disease Progression Pathway for Early Detection of Novel Corona Virus Covid-19. 2020. doi: 10.31222/osf.io/fu9p8
  53. Pan Y, Zhang D, Yang P, Leo LMP, Quanyi Wang. Viral load of SARS-CoV-2 in clinical samples. The Lancet infectious diseases. 2020;20(4): 411-412. doi: 10.1016/S1473-3099(20)30113-4
  54. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786. PMID: 32159775; PMCID: PMC7066521.
  55. Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, Xu H. Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA. 2020 Apr 21;323(15):1502-1503. doi: 10.1001/jama.2020.2783. PMID: 32105304; PMCID: PMC7047852.
  56. Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J. 2020 Apr 16;55(4):2000607. doi: 10.1183/13993003.00607-2020. PMID: 32269085; PMCID: PMC7144260.
  57. Ong EZ, ZiyingOng, Yvonne FZC, Wan YL, Natalie MYL, Shirin K, Salahudeen MHM, Kian S, Chan, Anthony TT, Antonio Bertoletti, Eng E, Jenny GH. A dynamic immune response shapes COVID-19 progression. Cell Host & Microbe. 2020 June;27(6): 879-882e2. doi: 10.1016/j.chom.2020.03.021
  58. Hageman JR. The Coronavirus Disease 2019 (COVID-19). Pediatr Ann. 2020 Mar 1;49(3):e99-e100. doi: 10.3928/19382359-20200219-01. PMID: 32155273.
  59. Pan X, Chen D, Xia Y, Wu X, Li T, Ou X, Zhou L, Liu J. Asymptomatic cases in a family cluster with SARS-CoV-2 infection. Lancet Infect Dis. 2020 Apr;20(4):410-411. doi: 10.1016/S1473-3099(20)30114-6. Epub 2020 Feb 19. PMID: 32087116; PMCID: PMC7158985.
  60. Hancock AS, Stairiker CJ, Boesteanu AC, Monzón-Casanova E, Lukasiak S, Mueller YM, Stubbs AP, García-Sastre A, Turner M, Katsikis PD. Transcriptome Analysis of Infected and Bystander Type 2 Alveolar Epithelial Cells during Influenza A Virus Infection Reveals In Vivo Wnt Pathway Downregulation. J Virol. 2018 Oct 12;92(21):e01325-18. doi: 10.1128/JVI.01325-18. PMID: 30111569; PMCID: PMC6189488.
  61. Qian Z, Travanty EA, Oko L, Edeen K, Berglund A, Wang J, Ito Y, Holmes KV, Mason RJ. Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol. 2013 Jun;48(6):742-8. doi: 10.1165/rcmb.2012-0339OC. PMID: 23418343; PMCID: PMC3727876.
  62. Tang NL, Chan PK, Wong CK, To KF, Wu AK, Sung YM, Hui DS, Sung JJ, Lam CW. Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome. Clin Chem. 2005 Dec;51(12):2333-40. doi: 10.1373/clinchem.2005.054460. Epub 2005 Sep 29. PMID: 16195357; PMCID: PMC7108146.
  63. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020 Jun;215:108427. doi: 10.1016/j.clim.2020.108427. Epub 2020 Apr 20. PMID: 32325252; PMCID: PMC7169933.
  64. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648. PMID: 32091533.
  65. Mossel EC, Wang J, Jeffers S, Edeen KE, Wang S, Cosgrove GP, Funk CJ, Manzer R, Miura TA, Pearson LD, Holmes KV, Mason RJ. SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells. Virology. 2008 Mar 1;372(1):127-35. doi: 10.1016/j.virol.2007.09.045. Epub 2007 Nov 26. PMID: 18022664; PMCID: PMC2312501.
  66. Wu J, Wu X, Zeng W, Guo D, Fang Z, Chen L, Huang H, Li C. Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features. Invest Radiol. 2020 May;55(5):257-261. doi: 10.1097/RLI.0000000000000670. PMID: 32091414; PMCID: PMC7147284.
  67. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18. Erratum in: Lancet Respir Med. 2020 Feb 25;: PMID: 32085846; PMCID: PMC7164771.
  68. Nikolaos MN, John GN, Lori BP, Jason CG, Yasuaki U, Huixing W, Atsushi S, Kara EL, Huan L, Mitchell RW, Kevan LH, Francis XMC. Mitogenic stimulation accelerates influenza-induced mortality by increasing susceptibility of alveolar type II cells to infection. 2017;114(32). E6613-E6622. doi: 10.1073/pnas.1621172114
  69. Ho JC, Chan KN, Hu WH, Lam WK, Zheng L, Tipoe GL, Sun J, Leung R, Tsang KW. The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia. Am J Respir Crit Care Med. 2001 Mar;163(4):983-8. doi: 10.1164/ajrccm.163.4.9909121. PMID: 11282777.
  70. Fan E, Brodie D, Slutsky AS. Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment. JAMA. 2018 Feb 20;319(7):698-710. doi: 10.1001/jama.2017.21907. PMID: 29466596.
  71. Ziehr DR, Alladina J, Petri CR, Maley JH, Moskowitz A, Medoff BD, Hibbert KA, Thompson BT, Hardin CC. Reply to Epelbaum: Standards and Stereotypes in COVID-19. Am J Respir Crit Care Med. 2020 Aug 1;202(3):470-471. doi: 10.1164/rccm.202005-1944LE. PMID: 32510977; PMCID: PMC7397799.
  72. Ziehr DR, Alladina J, Petri CR, Maley JH, Moskowitz A, Medoff BD, Hibbert KA, Thompson BT, Hardin CC. Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study. Am J Respir Crit Care Med. 2020 Jun 15;201(12):1560-1564. doi: 10.1164/rccm.202004-1163LE. PMID: 32348678; PMCID: PMC7301734.
  73. Martinez-Rojas MA, Vega-Vega O, Bobadilla NA. Is the kidney a target of SARS-CoV-2? Am J Physiol Renal Physiol. 2020 Jun 1;318(6):F1454-F1462. doi: 10.1152/ajprenal.00160.2020. Epub 2020 May 15. PMID: 32412303; PMCID: PMC7303722.
  74. Diao B, Wang C, Wang R. Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. medRxiv. 2020. doi: 10.1101/2020.03.04.20031120.
  75. Zhang YM, Zhang H. Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Clin J Am Soc Nephrol. 2020 Jul 1;15(7):1044-1046. doi: 10.2215/CJN.04370420. Epub 2020 Apr 23. PMID: 32327413; PMCID: PMC7341780.
  76. Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C, Sjöstedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Pontén F. Proteomics. Tissue-based map of the human proteome. Science. 2015 Jan 23;347(6220):1260419. doi: 10.1126/science.1260419. PMID: 25613900.
  77. Molina R, Oliva B, Fernandez FN. A collection of designed peptides to target SARS-Cov-2–ACE2 interaction: PepI-Covid19 database. bioRxiv. 2020. doi: 10.1101/2020.04.28.051789
  78. Zhang YM, Zhang H. Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Clin J Am Soc Nephrol. 2020 Jul 1;15(7):1044-1046. doi: 10.2215/CJN.04370420. Epub 2020 Apr 23. PMID: 32327413; PMCID: PMC7341780.
  79. Zhang F, Liang Y. Potential risk of the kidney vulnerable to novel coronavirus 2019 infection. Am J Physiol Renal Physiol. 2020 May 1;318(5):F1136-F1137. doi: 10.1152/ajprenal.00085.2020. Epub 2020 Mar 30. PMID: 32223555; PMCID: PMC7191387.
  80. Lunwen W, Xun L, Hui C, Shaonan Y, Yan L, Dong L, Zuojiong G. SARS-CoV-2 infection does not significantly cause acute renal injury: an analysis of 116 hospitalized patients with COVID-19 in a single hospital, Wuhan, China. 2020. doi: 10.1101/2020.02.19.20025288
  81. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5. PMID: 32139904; PMCID: PMC7095524.
  82. Groß S, Jahn C, Cushman S, ChristianBär, ThomasThum. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications. Journal of Molecular and Cellular Cardiology. 2020;144: 47-53. doi: 10.1016/j.yjmcc.2020.04.031
  83. Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020 May;45(3):230-232. doi: 10.1007/s00059-020-04909-z. PMID: 32140732; PMCID: PMC7080076.
  84. Natoli S, Oliveira V, Calabresi P, Maia LF, Pisani A. Does SARS-Cov-2 invade the brain? Translational lessons from animal models. Eur J Neurol. 2020 Apr 25:10.1111/ene.14277. doi: 10.1111/ene.14277. Epub ahead of print. PMID: 32333487; PMCID: PMC7267377.
  85. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M, Sakata H, Kondo K, Myose N, Nakao A, Takeda M, Haro H, Inoue O, Suzuki-Inoue K, Kubokawa K, Ogihara S, Sasaki T, Kinouchi H, Kojin H, Ito M, Onishi H, Shimizu T, Sasaki Y, Enomoto N, Ishihara H, Furuya S, Yamamoto T, Shimada S. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020 May;94:55-58. doi: 10.1016/j.ijid.2020.03.062. Epub 2020 Apr 3. PMID: 32251791; PMCID: PMC7195378.
  86. Zanin L, Saraceno G, Panciani PP, Renisi G, Signorini L, Migliorati K, Fontanella MM. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir (Wien). 2020 Jul;162(7):1491-1494. doi: 10.1007/s00701-020-04374-x. Epub 2020 May 4. PMID: 32367205; PMCID: PMC7197630.
  87. Paniz-Mondolfi A, Bryce C, Grimes Z. Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2). Journal of Medical Virology. 2020.
  88. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, Zhang W, Wang Y, Bao S, Li Y, Wu C, Liu H, Liu D, Shao J, Peng X, Yang Y, Liu Z, Xiang Y, Zhang F, Silva RM, Pinkerton KE, Shen K, Xiao H, Xu S, Wong GWK; Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 Infection in Children. N Engl J Med. 2020 Apr 23;382(17):1663-1665. doi: 10.1056/NEJMc2005073. Epub 2020 Mar 18. PMID: 32187458; PMCID: PMC7121177.
  89. Lucio V, Angelo M, Annalisa G, Laura M, Maurizio R, Matteo C, Ezio B, Lorenzo DA. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. The Lancet. 2020 June;395(10239): 1771-1778. doi: 10.1016/S0140-6736(20)31103-X
  90. Grassia R, Soro S, Conti CB. Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not? Inflamm Bowel Dis. 2020 Jun 18;26(7):e71. doi: 10.1093/ibd/izaa110. PMID: 32386056; PMCID: PMC7239122.
  91. Kumar A, Faiq MA, Pareek V, Raza K, Narayan RK, Prasoon P, Kumar P, Kulandhasamy M, Kumari C, Kant K, Singh HN, Qadri R, Pandey SN, Kumar S. Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients. Med Hypotheses. 2020 Nov;144:110271. doi: 10.1016/j.mehy.2020.110271. Epub 2020 Sep 13. PMCID: PMC7487155.
  92. Carvalho A, Alqusairi R, Adams A, Paul M, Kothari N, Peters S, DeBenedet AT. SARS-CoV-2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID-19 Disease. Am J Gastroenterol. 2020 Jun;115(6):942-946. doi: 10.14309/ajg.0000000000000667. PMID: 32496741; PMCID: PMC7172485.
  93. Tang YW, Schmitz JE, Persing DH, Stratton CW. Laboratory Diagnosis of COVID-19: Current Issues and Challenges. J Clin Microbiol. 2020 May 26;58(6):e00512-20. doi: 10.1128/JCM.00512-20. PMID: 32245835; PMCID: PMC7269383.
  94. Chan JF, Yip CC, To KK, Tang TH, Wong SC, Leung KH, Fung AY, Ng AC, Zou Z, Tsoi HW, Choi GK, Tam AR, Cheng VC, Chan KH, Tsang OT, Yuen KY. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens. J Clin Microbiol. 2020 Apr 23;58(5):e00310-20. doi: 10.1128/JCM.00310-20. PMID: 32132196; PMCID: PMC7180250.
  95. Kontou PI, Braliou GG, Dimou NL, Nikolopoulos G, Bagos PG. Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis. Diagnostics (Basel). 2020 May 19;10(5):319. doi: 10.3390/diagnostics10050319. PMID: 32438677; PMCID: PMC7278002.
  96. Liang G, Yihui H, Mengqi T, Shipei W, Sichao C, Wei L, Wei Z, Danyang C, Lin Z, Min W, Meng W, Qi H, Haibo X, Wen Z, Zeming L. Confusion and Thinking on the Diagnosis and Treatment of Patients with Negative RT-PCR Results for SARS-CoV-2. 2020; 1-28.
  97. https://tinyurl.com/yxu2cmhl
  98. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000 Jun 15;28(12):E63. doi: 10.1093/nar/28.12.e63. PMID: 10871386; PMCID: PMC102748.
  99. Nagamine K, Hase T, Notomi T. Accelerated reaction by loop-mediated isothermal amplification using loop primers. Mol Cell Probes. 2002 Jun;16(3):223-9. doi: 10.1006/mcpr.2002.0415. PMID: 12144774.
  100. Kashir J, Yaqinuddin A. Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19. Med Hypotheses. 2020 Aug;141:109786. doi: 10.1016/j.mehy.2020.109786. Epub 2020 Apr 25. PMID: 32361529; PMCID: PMC7182526.
  101. Poon LL, Leung CS, Tashiro M, Chan KH, Wong BW, Yuen KY, Guan Y, Peiris JS. Rapid detection of the severe acute respiratory syndrome (SARS) coronavirus by a loop-mediated isothermal amplification assay. Clin Chem. 2004 Jun;50(6):1050-2. doi: 10.1373/clinchem.2004.032011. Epub 2004 Mar 30. PMID: 15054079; PMCID: PMC7108160.
  102. Shirato K, Yano T, Senba S, Akachi S, Kobayashi T, Nishinaka T, Notomi T, Matsuyama S. Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol J. 2014 Aug 8;11:139. doi: 10.1186/1743-422X-11-139. PMID: 25103205; PMCID: PMC4132226.
  103. Wei EH, Boon L, Chia CH, Dan X, Wei W, Yejiong Y, Huidong J, Yun W, Yida Z, Mengmeng J, Hong C, Xiuming Z, Hui w, Zhanfeng C. RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2. Microb Biotechnol. 2020; doi: 10.1111/1751-7915.13586
  104. El-Tholoth M, Bau HH, Song J. A Single and Two-Stage, Closed-Tube, Molecular Test for the 2019 Novel Coronavirus (COVID-19) at Home, Clinic, and Points of Entry. ChemRxiv [Preprint]. 2020 Feb 19. doi: 10.26434/chemrxiv.11860137. PMID: 32511284; PMCID: PMC7251958.
  105. Lu R, Wu X, Wan Z, Li Y, Jin X, Zhang C. A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2. Int J Mol Sci. 2020 Apr 18;21(8):2826. doi: 10.3390/ijms21082826. PMID: 32325642; PMCID: PMC7216271.
  106. Yu L, Wu S, Hao X, Dong X, Mao L, Pelechano V, Chen WH, Yin X. Rapid Detection of COVID-19 Coronavirus Using a Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) Diagnostic Platform. Clin Chem. 2020 Jul 1;66(7):975-977. doi: 10.1093/clinchem/hvaa102. PMID: 32315390; PMCID: PMC7188121.
  107. Dong D, Tang Z, Wang S, Hui H, Gong L, Lu Y, Xue Z, Liao H, Chen F, Yang F, Jin R, Wang K, Liu Z, Wei J, Mu W, Zhang H, Jiang J, Tian J, Li H. The role of imaging in the detection and management of COVID-19: a review. IEEE Rev Biomed Eng. 2020 Apr 27;PP. doi: 10.1109/RBME.2020.2990959. Epub ahead of print. PMID: 32356760.
  108. Adam B, Xueyan M, Mingqian H, Yang Y, Zahi A, Ning Z, Kaiyue D, Bin L, Xiqi Z, Kunwei L, Shaolin L, Hong S, Adam J, Michael C. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology. 2020;295(3): 200463. doi: 10.1148/radiol.2020200463
  109. Deng Y, Lei L, Chen Y, Zhang W. The potential added value of FDG PET/CT for COVID-19 pneumonia. Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1634-1635. doi: 10.1007/s00259-020-04767-1. Epub 2020 Mar 21. PMID: 32198615; PMCID: PMC7087529.
  110. Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, Chen H, Ding X, Zhao H, Zhang H, Wang C, Zhao J, Sun X, Tian R, Wu W, Wu D, Ma J, Chen Y, Zhang D, Xie J, Yan X, Zhou X, Liu Z, Wang J, Du B, Qin Y, Gao P, Qin X, Xu Y, Zhang W, Li T, Zhang F, Zhao Y, Li Y, Zhang S. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8. PMID: 32268022; PMCID: PMC7161262.
  111. Ballout RA, Sviridov D, Bukrinsky MI, Remaley AT. The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications. FASEB J. 2020 Jun;34(6):7253-7264. doi: 10.1096/fj.202000654R. Epub 2020 May 5. PMID: 32367579; PMCID: PMC7383733.
  112. Chen WH, Hotez PJ, Bottazzi ME. Potential for developing a SARS-CoV Receptor-Binding Domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19. Hum Vaccin Immunother. 2020 Jun 2;16(6):1239-1242. doi: 10.1080/21645515.2020.1740560. Epub 2020 Apr 16. PMID: 32298218; PMCID: PMC7482854.
  113. Shi F, Xie Y, Shi L, Xu W. Viral RNA polymerase: a promising antiviral target for influenza A virus. Curr Med Chem. 2013;20(31):3923-34. doi: 10.2174/09298673113209990208. PMID: 23931274.
  114. van Doremalen N, Lambe T, Spencer A, Belij-Rammerstorfer S, Purushotham JN, Port JR, Avanzato V, Bushmaker T, Flaxman A, Ulaszewska M, Feldmann F, Allen ER, Sharpe H, Schulz J, Holbrook M, Okumura A, Meade-White K, Pérez-Pérez L, Bissett C, Gilbride C, Williamson BN, Rosenke R, Long D, Ishwarbhai A, Kailath R, Rose L, Morris S, Powers C, Lovaglio J, Hanley PW, Scott D, Saturday G, de Wit E, Gilbert SC, Munster VJ. ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques. bioRxiv [Preprint]. 2020 May 13:2020.05.13.093195. doi: 10.1101/2020.05.13.093195. Update in: Nature. 2020 Jul 30; PMID: 32511340; PMCID: PMC7241103.
  115. Shi Y, Wang N, Zou QM. [Progress and challenge of vaccine development against 2019-novel coronavirus (2019-nCoV)]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Jun 6;54(6):614-619. Chinese. doi: 10.3760/cma.j.cn112150-20200317-00366. PMID: 32234130.
  116. Singh T, Heston SM, Langel SN, Blasi M, Hurst JH, Fouda GG, Kelly MS, Permar SR. Lessons from COVID-19 in children: Key hypotheses to guide preventative and therapeutic strategies. Clin Infect Dis. 2020 May 8:ciaa547. doi: 10.1093/cid/ciaa547. Epub ahead of print. PMID: 32382748; PMCID: PMC7239258.
  117. Smith TRF, Patel A, Ramos S. Rapid development of a synthetic DNA vaccine for COVID-19. 2020, Research Square.
  118. https://tinyurl.com/y4juygdl
  119. Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, Li Y, Zhu L, Wang N, Lv Z, Gao H, Ge X, Kan B, Hu Y, Liu J, Cai F, Jiang D, Yin Y, Qin C, Li J, Gong X, Lou X, Shi W, Wu D, Zhang H, Zhu L, Deng W, Li Y, Lu J, Li C, Wang X, Yin W, Zhang Y, Qin C. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020 Jul 3;369(6499):77-81. doi: 10.1126/science.abc1932. Epub 2020 May 6. PMID: 32376603; PMCID: PMC7202686.
  120. Ella KM, Mohan VK. Coronavirus Vaccine: Light at the End of the Tunnel. Indian Pediatr. 2020 May 15;57(5):407-410. doi: 10.1007/s13312-020-1812-z. Epub 2020 Apr 15. PMID: 32291382; PMCID: PMC7240229.
  121. Sheahan TP, Sims AC, Leist SR, Schäfer A, Won J, Brown AJ, Montgomery SA, Hogg A, Babusis D, Clarke MO, Spahn JE, Bauer L, Sellers S, Porter D, Feng JY, Cihlar T, Jordan R, Denison MR, Baric RS. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020 Jan 10;11(1):222. doi: 10.1038/s41467-019-13940-6. PMID: 31924756; PMCID: PMC6954302.
  122. Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O’Meara MJ, Rezelj VV, Guo JZ, Swaney DL, Tummino TA, Hüttenhain R, Kaake RM, Richards AL, Tutuncuoglu B, Foussard H, Batra J, Haas K, Modak M, Kim M, Haas P, Polacco BJ, Braberg H, Fabius JM, Eckhardt M, Soucheray M, Bennett MJ, Cakir M, McGregor MJ, Li Q, Meyer B, Roesch F, Vallet T, Mac Kain A, Miorin L, Moreno E, Naing ZZC, Zhou Y, Peng S, Shi Y, Zhang Z, Shen W, Kirby IT, Melnyk JE, Chorba JS, Lou K, Dai SA, Barrio-Hernandez I, Memon D, Hernandez-Armenta C, Lyu J, Mathy CJP, Perica T, Pilla KB, Ganesan SJ, Saltzberg DJ, Rakesh R, Liu X, Rosenthal SB, Calviello L, Venkataramanan S, Liboy-Lugo J, Lin Y, Huang XP, Liu Y, Wankowicz SA, Bohn M, Safari M, Ugur FS, Koh C, Savar NS, Tran QD, Shengjuler D, Fletcher SJ, O’Neal MC, Cai Y, Chang JCJ, Broadhurst DJ, Klippsten S, Sharp PP, Wenzell NA, Kuzuoglu-Ozturk D, Wang HY, Trenker R, Young JM, Cavero DA, Hiatt J, Roth TL, Rathore U, Subramanian A, Noack J, Hubert M, Stroud RM, Frankel AD, Rosenberg OS, Verba KA, Agard DA, Ott M, Emerman M, Jura N, von Zastrow M, Verdin E, Ashworth A, Schwartz O, d’Enfert C, Mukherjee S, Jacobson M, Malik HS, Fujimori DG, Ideker T, Craik CS, Floor SN, Fraser JS, Gross JD, Sali A, Roth BL, Ruggero D, Taunton J, Kortemme T, Beltrao P, Vignuzzi M, García-Sastre A, Shokat KM, Shoichet BK, Krogan NJ. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020 Jul;583(7816):459-468. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30. PMID: 32353859; PMCID: PMC7431030.
  123. Warren TK, Wells J, Panchal RG, Stuthman KS, Garza NL, Van Tongeren SA, Dong L, Retterer CJ, Eaton BP, Pegoraro G, Honnold S, Bantia S, Kotian P, Chen X, Taubenheim BR, Welch LS, Minning DM, Babu YS, Sheridan WP, Bavari S. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature. 2014 Apr 17;508(7496):402-5. doi: 10.1038/nature13027. Epub 2014 Mar 2. PMID: 24590073; PMCID: PMC7095208.
  124. Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Rawling M, Savory E, Stebbing J. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020 Feb 15;395(10223):e30-e31. doi: 10.1016/S0140-6736(20)30304-4. Epub 2020 Feb 4. Erratum in: Lancet. 2020 Jun 20;395(10241):1906. PMID: 32032529; PMCID: PMC7137985.
  125. Dierynck I, De Wit M, Gustin E, Keuleers I, Vandersmissen J, Hallenberger S, Hertogs K. Binding kinetics of darunavir to human immunodeficiency virus type 1 protease explain the potent antiviral activity and high genetic barrier. J Virol. 2007 Dec;81(24):13845-51. doi: 10.1128/JVI.01184-07. Epub 2007 Oct 10. PMID: 17928344; PMCID: PMC2168871.
  126. Wang Z, Chen X, Lu Y, Chen F, Zhang W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. 2020 Mar 16;14(1):64-68. doi: 10.5582/bst.2020.01030. Epub 2020 Feb 9. Erratum in: Biosci Trends. 2020;14(1):E1. PMID: 32037389.
  127. Fukui M, Kawaguchi K, Matsuura H. Does TB vaccination reduce COVID-19 infection? No evidence from a regression discontinuity analysis. No Evidence from a Regression Discontinuity Analysis. 2020 April. medRxiv. doi: 10.1101/2020.04.13.20064287
  128. Roujian L, Xiang Z, Juan L, Peihua N, Bo Y, Honglong W, Wenling W, Hao S, Baoying H, Na Z, Yuhai B, Xuejun M, Faxian Z, Liang W, Tao H, Hong Z, Zhenhong H, Weimin Z, Li Z, Jing C, Yao M, Ji W, Yang L, Jianying Y, Zhihao X, Jinmin M, William JL, Dayan W, Wenbo X, Edward CH, George FG, Guizhen W, Weijun C, Weifeng S, Wenjie T. 2020 January. doi: 10.1016/S0140-6736(20)30251-8
  129. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20. PMID: 32205204; PMCID: PMC7102549.
  130. Sandeep S, McGregor K. Energetics Based Modeling of Hydroxychloroquine and Azithromycin Binding to the SARS-CoV-2 Spike (S) Protein-ACE2 Complex. 2020.
  131. https://tinyurl.com/y4oozfb8
  132. Srinivasa A, Tosounidou S, Gordon C. Increased Incidence of Gastrointestinal Side Effects in Patients Taking Hydroxychloroquine: A Brand-related Issue? J Rheumatol. 2017 Mar;44(3):398. doi: 10.3899/jrheum.161063. PMID: 28250164.
  133. Waetzig V, Riffert J, Cordt J, Reinecke K, Haeusgen W, Boehm R, Cascorbi I, Herdegen T. Neurodegenerative effects of azithromycin in differentiated PC12 cells. Eur J Pharmacol. 2017 Aug 15;809:1-12. doi: 10.1016/j.ejphar.2017.05.002. Epub 2017 May 4. PMID: 28479141.
  134. Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C, Yuan M, Huang J, Wang Z, Yu J, Gao X, Wang D, Yu X, Li L, Zhang J, Wu X, Li B, Xu Y, Chen W, Peng Y, Hu Y, Lin L, Liu X, Huang S, Zhou Z, Zhang L, Wang Y, Zhang Z, Deng K, Xia Z, Gong Q, Zhang W, Zheng X, Liu Y, Yang H, Zhou D, Yu D, Hou J, Shi Z, Chen S, Chen Z, Zhang X, Yang X. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6. PMID: 32253318; PMCID: PMC7196837.
  135. Zhu C, Wu Y, Liu H, Ban Y, Ma X, Zhang Z. Early pulmonary rehabilitation for SARS-CoV-2 pneumonia: Experience from an intensive care unit outside of the Hubei province in China. Heart Lung. 2020 Sep-Oct;49(5):449-450. doi: 10.1016/j.hrtlng.2020.04.007. Epub 2020 Apr 16. PMID: 32312554; PMCID: PMC7161510.
  136. Kurtaiş Aytür Y, Köseoğlu BF, Özyemişçi Taşkıran Ö, Ordu-Gökkaya NK, Ünsal Delialioğlu S, Sonel Tur B, Sarıkaya S, Şirzai H, Tekdemir Tiftik T, Alemdaroğlu E, Ayhan FF, Duyur Çakıt BD, Genç A, Gündoğdu İ, Güzel R, Demirbağ Karayel D, Bilir Kaya B, Öken Ö, Özdemir H, Soyupek F, Tıkız C. Pulmonary rehabilitation principles in SARS-COV-2 infection (COVID-19): A guideline for the acute and subacute rehabilitation. Turk J Phys Med Rehabil. 2020 May 12;66(2):104-120. doi: 10.5606/tftrd.2020.6444. PMID: 32760887; PMCID: PMC7401689.
  137. Jangra MK, Saxena A. Significance of physiotherapy in “SARS-CoV-2/COVID-19: An Epidemic”. Ann Thorac Med. 2020 Jul-Sep;15(3):179-180. doi: 10.4103/atm.ATM_169_20. Epub 2020 Jun 18. PMID: 32831942; PMCID: PMC7423205.
  138. Dehesh P. Risk Management of COVID-19 Infection in Physiotherapy: Recommendations. Journal of Biology and Today’s World. 2020;9(7): 1-2.
  139. https://tinyurl.com/y42lz2xp
  140. Diwate AD. Role of Physiotherapy in Covid-19 Patients. Vims. Journal of Physical Therapy. 2020;2(1): 1-2.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership